These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29301920)

  • 1. Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.
    Tromeur C; Sanchez O; Presles E; Pernod G; Bertoletti L; Jego P; Duhamel E; Provost K; Parent F; Robin P; Deloire L; Leven F; Mingant F; Bressollette L; Le Roux PY; Salaun PY; Nonent M; Pan-Petesch B; Planquette B; Girard P; Lacut K; Melac S; Mismetti P; Laporte S; Meyer G; Mottier D; Leroyer C; Couturaud F;
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29301920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
    Raj L; Presles E; Le Mao R; Robin P; Sanchez O; Pernod G; Bertoletti L; Jego P; Lemarié CA; Leven F; Hoffmann C; Planquette B; Le Roux PY; Slaun PY; Nonent M; Girard P; Lacut K; Mélac S; Guégan M; Mismetti P; Laporte S; Meyer G; Leroyer C; Tromeur C; Couturaud F;
    Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective Cohort.
    Orione C; Tromeur C; Le Mao R; Le Floch PY; Robin P; Hoffmann C; Bressollette L; Nonent M; Le Roux PY; Salaun PY; Guegan M; Poulhazan E; Lacut K; Leroyer C; Lemarié CA; Couturaud F
    Thromb Haemost; 2021 Jul; 121(7):955-963. PubMed ID: 33469906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE Trial.
    Raj L; Robin P; Le Mao R; Presles E; Tromeur C; Sanchez O; Pernod G; Bertoletti L; Jego P; Leven F; Lemarié CA; Martin A; Planquette B; Le Roux PY; Salaun PY; Nonent M; Girard P; Lacut K; Melac S; Mismetti P; Laporte S; Meyer G; Leroyer C; Couturaud F;
    Thromb Haemost; 2019 Sep; 119(9):1489-1497. PubMed ID: 31230343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
    Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI
    Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther M; White RH; Vickars L; Bazarjani S; Le Gal G
    Thromb Res; 2018 Feb; 162():104-109. PubMed ID: 29224973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial].
    Couturaud F; Pernod G; Pison C; Mismetti P; Sanchez O; Meyer G; Parent F; Girard P; Simonneau G; Drouet L; Gueret P; Jego P; Delaval P; Duhamel E; Gruel Y; Delahousse B; Regina S; Pottier P; Connaud J; Lecomte F; Provost K; Vilmans N; Gosset X; Bura-Rivière A; Meach G; Lacut K; Bosson JL; Guillot K; Mottier D; Leroyer C
    Rev Mal Respir; 2008 Sep; 25(7):885-93. PubMed ID: 18946418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Planquette B; Ferré A; Peron J; Vial-Dupuy A; Pastre J; Mourin G; Emmerich J; Collignon MA; Meyer G; Sanchez O
    Thromb Res; 2016 Dec; 148():70-75. PubMed ID: 27815969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism.
    Pesavento R; Filippi L; Palla A; Visonà A; Bova C; Marzolo M; Porro F; Villalta S; Ciammaichella M; Bucherini E; Nante G; Battistelli S; Muiesan ML; Beltramello G; Prisco D; Casazza F; Ageno W; Palareti G; Quintavalla R; Monti S; Mumoli N; Zanatta N; Cappelli R; Cattaneo M; Moretti V; Corà F; Bazzan M; Ghirarduzzi A; Frigo AC; Miniati M; Prandoni P;
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28546279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis.
    Becattini C; Giustozzi M; Cerdà P; Cimini LA; Riera-Mestre A; Agnelli G
    J Thromb Haemost; 2019 Aug; 17(8):1217-1228. PubMed ID: 31063646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
    Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
    Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism.
    Barco S; Corti M; Trinchero A; Picchi C; Ambaglio C; Konstantinides SV; Dentali F; Barone M
    J Thromb Haemost; 2017 Jul; 15(7):1436-1442. PubMed ID: 28439954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.